Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

Size: px
Start display at page:

Download "Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma"

Transcription

1 Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014

2 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe) Injection pens Development projects patch, sponge with active Ready to use medicines dry powder and infusion combined at use

3 Types of products Solution for nasal spray ready to use + the delivery device Non-sterile Auto-injector (+ needle) Oral solution + pump / dual chamber solution PRIMARY packaging Technology transfer Catheters (medicated)

4 Types of products Co-packaged Combined device and drug Cross referenced Don t develop the device ourself use contractors!!!

5 Purpose of the Seminar Review regulatory requirements: Medical device Drug Biologicals Human Cell and Tissue Therapy Products Combination Products Other? Quality System What is appropriate

6 Regulation of Drugs and Devices QSR / cgmp Regulations 21 CFR part 820 Quality System Regulation LEGISLATION REGULATION GOOD MANUFACTURING PRACTICE CURRENT

7 What is a Combination Product 21 CFR Part 3 MEDDEV Let s take a look

8 MED DEV Not legislation

9 Combination products: medical device, drug or both? Products that share the attributes of two categories of products In each scenario below, would you consider the combination product a medical device, medicinal product or equally both?

10 Drug Product, Device or Both? Contact lens care product that is indicated to disinfect, clean, rinse and hydrate contact lens Water to be used for injections, IV fluids and plasma volume expanders Syringe needle applicator and insulin form a single integral unit that is intended exclusively for use in the given combination for one-time administration of insulin and is not reusable Bone void filler to repair bone defects by which the primary action is a physical means (matrix) to provide a volume and scaffold for osteoconduction, where an additional medicinal substance is incorporated to assist and complement the action of the matrix by enhancing the growth of bone cells

11 Drug Product, Device or Both? (In the EU NOT in USA) Contact lens care product that is indicated to disinfect, clean, rinse and hydrate contact lens MD Accessory Water to be used for injections, IV fluids and plasma volume expanders Drug Product Syringe needle applicator and insulin form a single integral unit that is intended exclusively for use in the given combination for one-time administration of insulin and is not reusable Drug Product Bone void filler to repair bone defects by which the primary action is a physical means (matrix) to provide a volume and scaffold for osteoconduction, where an additional medicinal substance is incorporated to assist and complement the action of the matrix by enhancing the growth of bone cells Medical Device

12 In EU A combination product is regulated in Europe by either the Medical Device Directive MDD 93/42/EEC or the Medicinal Product Directive 2001/83/EC A general rule is that the primary mode of action (or function) of the product dictates how it is regulated Therefore, a product never can be both a medicinal product and possess CE Marking

13

14 Device Advice

15 What is a Combination Product

16 The Rule

17 Cross-labeled or Co-Packaged and Single-entity

18 Streamline

19 Add to GMP Regs 21 CFR 211

20 Add to QSR 21CFR Part 820

21 Questions put to FDA

22 More Questions

23 Combination Products This guidance has been prepared by the Office of Combination Products in the Office of the Commissioner in cooperation with the Center for Biologics Evaluation and Research (CBER), the Center for Drug Evaluation and Research (CDER), and the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration.

24 cgmp: For purposes of this guidance document, the term current good manufacturing practice refers to the current good manufacturing practice regulations for drugs and most biological products under: 21 CFR Parts 210 and 211, 21 CFR Parts for certain biological products 21 CFR Part 820: QSR for devices

25 What is a combination product? A product composed of any combination of: a drug and a device a biological product and a device a drug and a biological product a drug, device, and a biological product

26 21CFR 3.2(e) A combination product includes: 1.A product comprising two or more regulated components that are physically, chemically, or otherwise combined or mixed and produced as a single entity 2.Two or more separate products packaged together in a single package or as a unit 3.A drug, device, or biological product packaged separately that according to its investigational plan or proposed labeling is intended for use only with an approved individually specified drug, device, or biological product where both are required to achieve the intended use 4.Any investigational drug, device, or biological product packaged separately that according to its proposed labeling is for use only with another individually specified investigational drug, device, or biological product where both are required to achieve the intended use, indication, or effect.

27 CGMP Section 501 Food Drug and Cosmetics Act Section 501 authorizes FDA to establish current good manufacturing practice to avoid adulteration of drugs Adulteration includes a failure of the drug, biological product, or device to be manufactured in accordance with current good manufacturing practice, regardless of whether the product is actually deficient in some respect.

28 Purpose of GMP Current good manufacturing practice regulatory provisions are intended to ensure that the drug, biological product, or device is not adulterated so as: to ensure the product possesses adequate strength, quality, identity, and purity of a drug or biological product to ensure compliance with performance standards for a device.

29 21 cfr Part 820: QSR A: General B: Quality System Requirements C: Design Controls D: Document Controls E: Purchasing Controls F: Identification & Traceability G: Production and Process Controls H: Acceptance Activities I: Non Conforming Product J: CAPA K: Labeling and Packaging Controls L: Handling, Storage, Distribution & Installation M: Records N: Servicing O: Statistical Techniques

30 21 cfr part 211: GMP for Finished Pharmaceuticals A. General B. Organization & Personnel C. Facilities D. Equipment E. Component Controls F. Production Controls G. Packaging Controls H. Warehousing I. Laboratory Controls J. Documentation K. Returns and Recalls

31 CGMP vs QSR Combination Drugs Guideline Considerable overlap in the CGMP and QS regulations Both establish requirements for management, organization, and personnel Both require documentation and record keeping Both allow flexibility for manufacture FDA considers the CGMP and the QS regulations to be similar: they are meant to achieve the same goals Prior to combining product follow QSR or cgmp

32

33 Risk Management What could go wrong: With the drug With the device With the biological With the combination

34 Process Validation A Lifecycle Approach According to FDA 2011 paradigm not enough to do it once and forget about it you need to follow your process and continually show that it operates in a state of control

35 Process Validation A Lifecycle Approach Three steps in the PV: 1. Design stage 2. PPQ: process performance qualification 3. CPV: continued process verification

36 Process Validation: GHTF For the device gives statistics and can also be integrated with the FDA process validation guide from 2011 For the combination product if needed it could also be used

37 Quality Management Requires management involvement and commitment: resources For investigational drugs may have same individual performing Quality functions who is performing production or other functions. In this case, also have independent review Always involves SOPs, documentation and control of activities

38 Who OWNS the Combination Product within your company? Who is in Charge of Your Combination Product and its Product Specification File or Design History File Changes between development, tech transfer and commercial but IT MUST be defined Product compliance manager cross functional (in operations QA, changes, deviations, technical / subject matter expert)

39 Can responsibility be under design controls Do your design controls address DP as well as device and combination?

40 Personnel Training All personnel should have the education, experience and training or any combination thereof to enable that person to perform the assigned function In particular, personnel should have the appropriate experience to prepare the investigational product and be familiar with QC principles and acceptable methods for complying with the statutory requirement of CGMP

41 Facilities and Equipment Sufficient space, clean environment, appropriate construction Appropriate lighting, ventilation, and heating Appropriate cooling, plumbing, washing, and sanitation Appropriate air handling systems (e.g., laminar flow hoods) to aid in preventing contamination and cross-contamination of product Appropriate equipment that will not contaminate the product; not be reactive, additive, or absorptive with product; is properly maintained, calibrated, cleaned, and sanitized at appropriate intervals following written procedures Prevent contamination and cross-contamination

42 Purchasing Controls Written procedures describing: handling, review, and acceptance and control of components used in the production of an investigational product Components should be e.g. segregated, labeled, until examined or tested, as appropriate, and released for use in production Handle and store to prevent degradation or contamination Keep records of receipt and use Acceptance criteria, COAs and identity testing

43 QC Controls Test methods scientifically sound Validation? Stability indicating? OOS results: MUST have a written procedure and follow it Written, approved specifications Calibrated, qualified lab equipment Sample log-in Record keeping Standards.must be valid

44 Documentation Production records Laboratory records Deviation reporting Change: control and audit trails Batch release records

45 Packaging Controls May be particularly complex for clinical trials because of placebo Make sure no previous product Avoid mix-ups Document line clearance

46 Statistical Controls Use of valid statistical methods Define in written procedures DO NOT select the method AFTER you have the data May need assistance of statisticians beyond those within the company

47 Verification Confirmation by examination and provision of objective evidence that the particular requirements for a specific intended use can be fulfilled 21cfr 820 (Definitions)

48 Validation Validation: Providing documented evidence, in accordance with a preapproved protocol that a system, equipment, process, analytical method does what it is designed to do repeatedly and reliably. Have predetermined acceptance criteria / specification CDER / EU for drugs

49 Process Validation Establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications 21cfr (Definitions)

50 Design Validation Establishing by objective evidence that device specifications conform with user needs and intended use(s). 21cfr (Definitions)

51 Verification Confirmation by examination and provision of objective evidence that specified requirements have been fulfilled 21cfr (Definitions)

52 Subpart C - Design Controls (g): Design Validation: Establish and maintain procedures for validating the device design. Performed under defined operating conditions on initial production units, lots or batches. Ensure that devices conform to defined user needs and intended uses include testing of production units under actual or simulated conditions of use

53 Subpart C - Design Controls (g): Design Validation cont/: Include software validation and risk analysis, where appropriate Results including identification of the design, methods, date and individuals performing the validation documented in the DHF

54 21 cfr Process Validation Where the results of a process cannot be fully verified by subsequent inspection and test, the process shall be validated with a high degree of assurance and approved according to established procedures

55 21 cfr Process Validation A man who makes a mistake and does not correct it is making another mistake (Confucius) When changes or process deviations occur, the manufacturer shall review and evaluate the process and perform revalidation where appropriate.

56 Change Control Remember Remedia: It wasn t a change it was an improvement! All changes are initiated as improvements All changes have the potential to in validate a valid process

57 21 cfr (b) Production and process changes: Establish and maintain procedures for changes to a specification, method, process or procedure Changes should be verified or where appropriate validated before implementation and these activities documented. [don t forget to do a risk assessment]

58 READ the MEDICAL DEVICE DIRECTIVE FOR EUROPE

59 Thank You

Preamble to GMP Kefauver-Harris Amendments

Preamble to GMP Kefauver-Harris Amendments CGMP for Phase 1 Clinical Trials Harvey M. Arbit, PharmD, MBA, RAC, CCRP University of Minnesota Academic Health Center Director, IND/IDE Assistance Program Lead, Regulatory Knowledge and Support Clinical

More information

LIBRARY GUIDE: Pharmaceutical GMPs

LIBRARY GUIDE: Pharmaceutical GMPs LIBRARY GUIDE: Pharmaceutical GMPs Table of Contents Overview............................................................................ 3 Courses Listed by Functional Area....................................................

More information

Current Good Manufacturing Practice for PET Drugs - CGMP 21 CFR 212

Current Good Manufacturing Practice for PET Drugs - CGMP 21 CFR 212 Current Good Manufacturing Practice for PET Drugs - CGMP 21 CFR 212 CDER Office of Regulatory Policy Jane Axelrad, JD CDER Office of Compliance Brenda Uratani, Ph.D. CDER ONDQA Ravindra Kasliwal, Ph.D.

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

Corrective and Preventive Actions

Corrective and Preventive Actions Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What

More information

IVD Regulation Overview. Requirements to Assure Quality & Effectiveness

IVD Regulation Overview. Requirements to Assure Quality & Effectiveness IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug

More information

Current Good Manufacturing Practices Checklist For Pharmaceutical Manufacturers

Current Good Manufacturing Practices Checklist For Pharmaceutical Manufacturers Current Good Manufacturing Practices Checklist For Pharmaceutical Manufacturers Current Good Manufacturing Practices ( cgmps or GMPs ) for pharmaceutical manufacturers provide the methods and controls

More information

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters

How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing

More information

Guidance for Industry

Guidance for Industry Guidance for Industry CGMP for Phase 1 Investigational Drugs U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Synopsis: FDA Process Validation Guidance

Synopsis: FDA Process Validation Guidance Synopsis: FDA Process Validation Guidance This synopsis is a comparison of the draft version 2008 and the final version 2011 of the U.S. FDA Guidance Process Validation: General Principles and Practices.

More information

CMC Considerations for Combination Products

CMC Considerations for Combination Products CMC Considerations for Combination Products Co-Leaders: Nina Cauchon (Amgen); Doug Mead (Janssen R&D, LLC) Co-Speakers/Moderators: Ashley Boam (FDA); Scott Furness (FDA); Jason Lipman (Janssen R&D, LLC);

More information

HOW TO DEAL IN A REGULATED ENVIRONMENT. Matt Rigerman Director Operations & Quality Reichert, Inc. CMQ/OE, CSSBB, CQA

HOW TO DEAL IN A REGULATED ENVIRONMENT. Matt Rigerman Director Operations & Quality Reichert, Inc. CMQ/OE, CSSBB, CQA HOW TO DEAL IN A REGULATED ENVIRONMENT Matt Rigerman Director Operations & Quality Reichert, Inc. CMQ/OE, CSSBB, CQA AGENDA Origin of the FDA Medical Devices standard (21 CFR 820) Compliance strengthens

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments

More information

LIBRARY GUIDE. Online Courses. March 2012

LIBRARY GUIDE. Online Courses. March 2012 LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

LIBRARY GUIDE. Online Courses. September 2011

LIBRARY GUIDE. Online Courses. September 2011 LIBRARY GUIDE Online Courses September 2011 i Table of Contents Overview... 1 Course Descriptions (Listed alphabetically)... 2 A Guide to ISO 13485 The Quality Management System for Medical Devices (DEV50)....

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Process Validation: General Principles and Practices U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center

More information

GMP Inspection report

GMP Inspection report Inspected site(s): Activities Carried out: GMP Inspection report Manufacture of Active Substance Manufacture of Finished Medicinal Product Packaging Importing Laboratory Testing Batch Control and Batch

More information

Combination Products Regulation in the United States

Combination Products Regulation in the United States Combination Products Regulation in the United States Presenter: Scott Sardeson RAC US/EU 3M Health Care St. Paul, MN USA 1 Presentation Outline Combination products Definitions and Regulations Jurisdiction

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

Quality Program, CAPA and Audits

Quality Program, CAPA and Audits Quality Program, CAPA and Audits 3 rd Annual FDA and the Changing Paradigm for HCT/P Regulation January 25, 2007 Mary Malarkey, Director, OCBQ, CBER Summary CGTP CGMP QS Regulation Quality comparison CAPA

More information

Compliance, FDA Inspection and Product Quality. Jim Li, Ph.D. MBA

Compliance, FDA Inspection and Product Quality. Jim Li, Ph.D. MBA Compliance, FDA Inspection and Product Quality Jim Li, Ph.D. MBA Presentation Overview Regulations and Guidance: DP: 21 CFR Parts 210 & 211 DS: ICH Q7A System based approach FDA expectation in GMP compliance

More information

Elemental Impurities in APIs and Excipients - GMP Expectations

Elemental Impurities in APIs and Excipients - GMP Expectations Elemental Impurity Requirements in a Global Environment PQRI/USP Workshop, USP, Rockville, Maryland March 31 April 1, 2015 Elemental Impurities in APIs and Excipients - GMP Expectations Vibhakar Shah,

More information

2014 Annual Report on Inspections of Establishments

2014 Annual Report on Inspections of Establishments 2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

Basic Understanding of Good Manufacturing Practices Requirements and Execution. Minda Chiang Hong Kong Society for Quality Jan 2006

Basic Understanding of Good Manufacturing Practices Requirements and Execution. Minda Chiang Hong Kong Society for Quality Jan 2006 Basic Understanding of Good Manufacturing Practices Requirements and Execution Minda Chiang Hong Kong Society for Quality Jan 2006 1 Outline 1 To know why GMP 2 To know what GMP is 3 To know how to comply

More information

Pharmaceutical Industry Trends Approaches to Process Validation and Risk Management (Quality Systems and cgmps)

Pharmaceutical Industry Trends Approaches to Process Validation and Risk Management (Quality Systems and cgmps) Pharmaceutical Industry Trends Approaches to Process Validation and Risk Management (Quality Systems and cgmps) Anita R. Michael, Pharmaceutical Specialist FDA Office of Regulatory Affairs 1 Process Validation

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products

Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products DRAFT GUIDANCE This guidance document

More information

2012 The Society of the Plastics Industry, Inc. All rights reserved 1

2012 The Society of the Plastics Industry, Inc. All rights reserved 1 2012 The Society of the Plastics Industry, Inc. All rights reserved 1 COPYRIGHT AND DISCLAIMER This report is copyright 2012, The Society of the Plastics Industry, Inc. (SPI) Food, Drug, and Cosmetic Packaging

More information

Engineering Nanomedical Systems

Engineering Nanomedical Systems BME 695 November 8, 2011 Engineering Nanomedical Systems Lecture 15 GMP and issues of quality control manufacture of nanodelivery systems James F. Leary, Ph.D. SVM Endowed Professor of Nanomedicine Professor

More information

Medical Device Training Program 2015

Medical Device Training Program 2015 Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Read the Questions Carefully

Read the Questions Carefully PHT. 463- (Quality Control of Pharmaceutical Dosage Forms) Midterm Exam I Dr. Ibrahim A. Alsarra s Section Part I Read the Questions Carefully TRUE OR FALSE: Indicate whether the statement is true or false

More information

Comparison between FDA QSR and ISO 13485

Comparison between FDA QSR and ISO 13485 Comparison between FDA QSR and ISO 13485 Most countries in the world including the Europe, for the conformity assessment of medical devices to be used by their countrymen, assess not only whether the product

More information

Questions and Answers on the interpretation of ASEAN GMP Guideline for Cosmetic

Questions and Answers on the interpretation of ASEAN GMP Guideline for Cosmetic Questions and Answers on the interpretation of ASEAN GMP Guideline for Cosmetic The advice given here should serve as guidance only. You should always make reference to the ASEAN Cosmetic Directive. I.

More information

How to overcome Non compliance (483) related To manufacturing of Drug Products and observations Found during the audits?

How to overcome Non compliance (483) related To manufacturing of Drug Products and observations Found during the audits? How to overcome Non compliance (483) related To manufacturing of Drug Products and observations Found during the audits? IPA Maharashtra Seminar at SciTech Centre Jogeshwari Mumbai on 31.01.2014 By Sudhir

More information

Standards for Laboratory Facilities

Standards for Laboratory Facilities Standards for Laboratory Facilities Version 2.1 APPROVED 24 FEBRUARY 2014 Article I. General Provisions Section 1.01 The facility shall be of suitable size and construction to facilitate the proper conduct

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories

More information

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH

More information

Organization of QA cgmp compliance. BIT 230 Chapters 1 and 2 (Huxsoll)

Organization of QA cgmp compliance. BIT 230 Chapters 1 and 2 (Huxsoll) Organization of QA cgmp compliance BIT 230 Chapters 1 and 2 (Huxsoll) TQM Total Quality Management Approach a company uses day to day 7 strategies Leadership Information and analysis Strategic planning

More information

Quality Information. Buchs Manufacturing Site

Quality Information. Buchs Manufacturing Site Buchs Manufacturing Site Related Documents Buchs ISO 9001:2008 Certificate Buchs cgmp Certificate Buchs ISO 13485:2012 Certificate Buchs ISO 17025:2005/ ISO Guide 34 Certificate Buchs Management System

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

ICH Q10 - Pharmaceutical Quality System

ICH Q10 - Pharmaceutical Quality System WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,

More information

Beamex. Calibration White Paper. Calibration in a regulatory environment. World-class calibration solutions

Beamex. Calibration White Paper.  Calibration in a regulatory environment. World-class calibration solutions Beamex Calibration White Paper info@beamex.com Calibration in a regulatory environment World-class calibration solutions Calibration in a regulatory environment In areas where instrument accuracy is critical

More information

Medical Device Quality Agreement Template

Medical Device Quality Agreement Template Medical Device Quality Agreement Template Prepared by Dan O Leary Ombu Enterprises, LLC 3 Forest Ave. Swanzey, NH 03446 603-209-0600 This document is intended to form the basis for a Supplier Agreement

More information

Good Manufacturing Practices (GMPs) More than a few Numbers!

Good Manufacturing Practices (GMPs) More than a few Numbers! Good Manufacturing Practices (GMPs) More than a few Numbers! Where Do We Find Them? Depends on what you want. Are you looking for good manufacturing practices for Blood and Blood Products Tissues (HCT/Ps)

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

MeriCal Quality Profile

MeriCal Quality Profile January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.

More information

QUALITY RISK MANAGEMENT (QRM): A REVIEW

QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739

More information

COMMISSION DIRECTIVE 2003/94/EC

COMMISSION DIRECTIVE 2003/94/EC L 262/22 COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Correspondence between ISO 9001:2000, ISO/FDIS 13485:2003, and the US Quality System Regulation

Correspondence between ISO 9001:2000, ISO/FDIS 13485:2003, and the US Quality System Regulation Correspondence between ISO 9001:2000,, and the US Quality System Regulation 1 Scope 1.1 General This International Standard specifies requirements for a quality management system where an organization

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

GUIDELINES FOR GOOD MANUFACTURING PRACTICE FOR PLASTIC MATERIALS AND ARTICLES INTENDED FOR FOOD CONTACT APPLICATIONS

GUIDELINES FOR GOOD MANUFACTURING PRACTICE FOR PLASTIC MATERIALS AND ARTICLES INTENDED FOR FOOD CONTACT APPLICATIONS GUIDELINES FOR GOOD MANUFACTURING PRACTICE FOR PLASTIC MATERIALS AND ARTICLES INTENDED FOR FOOD CONTACT APPLICATIONS These industry guidelines have been drafted to support individual companies in the supply

More information

Manufacturing Process Qualification & Validation. Naren Patel. Naren Patel 1

Manufacturing Process Qualification & Validation. Naren Patel. Naren Patel 1 Manufacturing Process Qualification & Validation Naren Patel Naren Patel 1 Manufacturing Process Qualification & Validation Tutorial Why to Validate What to Validate Program How to Perform successful Validation

More information

Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products

Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products Version 1.3 Drug Office, Department of Health. Contents list 1. QUALITY MANAGEMENT... 4 2. PERSONNEL...

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

Pharmaceutical Quality System Bringing cgmp into the 21 st Century. Granite State 15 March 2012 Theresa McCarthy

Pharmaceutical Quality System Bringing cgmp into the 21 st Century. Granite State 15 March 2012 Theresa McCarthy Pharmaceutical Quality System Bringing cgmp into the 21 st Century Granite State 15 March 2012 Theresa McCarthy Agenda International Conference on Harmonization ICH Q10 Pharmaceutical Quality System Relationship

More information

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control.

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control. SOP Number: SOP -001 Page 1 of 5 4/18/2013 Effective I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control. II. SCOPE All SOP s

More information

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European

More information

Overview of Medical Device Design Controls in the US. By Nandini Murthy, MS, RAC

Overview of Medical Device Design Controls in the US. By Nandini Murthy, MS, RAC Overview of Medical Device Controls in the US By Nandini Murthy, MS, RAC 18 controls are a regulatory requirement for medical devices. In the US, compliance with the design controls section of 21 Code

More information

Guide to Good Manufacturing Practice of Cosmetic Products

Guide to Good Manufacturing Practice of Cosmetic Products Guide to Good Manufacturing Practice of Cosmetic Products IA-G0048-2 2 APRIL 2016 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS

More information

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors FDA Institutional Review Board Inspections Additional copies are available from: Office of Good Clinical Practice Office of Special

More information

Guidance for Industry: Starting Material Supplier Management

Guidance for Industry: Starting Material Supplier Management Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

Harmonizing Change Control Processes Globally

Harmonizing Change Control Processes Globally Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

Medical Device Directive 2007/47/EC What is New? Are we moving towards Drug Rules?

Medical Device Directive 2007/47/EC What is New? Are we moving towards Drug Rules? Medical Device Directive 2007/47/EC What is New? Are we moving towards Drug Rules? CEMO Congress, Paris, February 3rd, 2011 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs Agenda

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing GMP-inspections Questionnaire for preparing GMP-inspections Dr. Christine Oechslein, Max Lazar, Thomas Halfmann Here you will find answers to the following questions: What questions

More information

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle Process Performance Qualification Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle A LIFECYCLE Approach to Process Validation? Lifecycle [ICH Q8(R2)]: All phases

More information

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1 Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and

More information

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4 Ref. Ares(2015)283695-23/01/2015 PT CHAPTER 5 PRODUCTION EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy EudraLex

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

Pharmaceutical Wholesaler Site Inspection Checklist

Pharmaceutical Wholesaler Site Inspection Checklist Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.2 Status : APPROVED Effective: 9/25/2015 Page 2 of 23 Quality Manual Table of Contents

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Document issued on: June 2004 U.S. Department of Health and Human Services Food and Drug Administration

More information

Annex 9 Guide to good storage practices for pharmaceuticals 1

Annex 9 Guide to good storage practices for pharmaceuticals 1 World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities

More information

In vitro Device Regulation

In vitro Device Regulation In vitro Device Regulation Molecular Pathologists Reagent (Analyte) Manufacturers High Complexity Clinical Labs Commercial Academic in Vitro Diagnostics Manufacturers Drug Developers large & small 2 States

More information

Principles of Lean Six Sigma and CAPA

Principles of Lean Six Sigma and CAPA Principles of Lean Six Sigma and CAPA Eugenio Longo, PhD. Industrial Advisor & Visiting Professor for Universities Agenda : Part 1 Lean Six Sigma Overview Lean and 6 Sigma integration Work shop + Quiz

More information

[DOCKET NO. 91N-0450] GUIDELINE FOR QUALITY ASSURANCE IN BLOOD ESTABLISHMENTS. July 11, For further information about this document, contact:

[DOCKET NO. 91N-0450] GUIDELINE FOR QUALITY ASSURANCE IN BLOOD ESTABLISHMENTS. July 11, For further information about this document, contact: [DOCKET NO. 91N-0450] GUIDELINE FOR QUALITY ASSURANCE IN BLOOD ESTABLISHMENTS July 11, 1995 For further information about this document, contact: Center for Biologics Evaluation and Research (HFM-635)

More information

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION 1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information

More information

Gaining Multiple Benefits from Required GMP Refresher Training

Gaining Multiple Benefits from Required GMP Refresher Training Gaining Multiple Benefits from Required GMP Refresher Training Gaining Multiple Benefits from Required GMP Refresher Training By Ellen Leinfuss, SVP, Life Science and Dave Peterson, Director, GMP Education

More information

Quality System: Design Control Procedure - Appendix

Quality System: Design Control Procedure - Appendix Quality System: Design Control Procedure - Appendix Page 1 of 10 Quality System: Design Control Procedure - Appendix CORP Medical Products Various details have been removed, indicated by [ ] 1. Overview

More information

Community Guide to Good Practice For Feed Additive and Premixture Operators

Community Guide to Good Practice For Feed Additive and Premixture Operators Community Guide to Good Practice For Feed Additive and Premixture Operators INTRODUCTION This European Guide of Practice for Animal Feed Additive and Premixture Operators ( Guide ) responds to the Regulation

More information

Manufacturing Cellular Products for International Clinical Trials

Manufacturing Cellular Products for International Clinical Trials Manufacturing Cellular Products for International Clinical Trials Q U A L I T Y A N D O P E R A T I O N S T R A C K 7 4 / 2 5 / 1 4 1 3 : 4 5-1 5 : 1 5 Olive J Sturtevant, MHP,MT (ASCP)SBB, CQA Director

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information